+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bristol-Myers Squibb - logo

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

PD-1 & PD-L1 Inhibitors Market by Product Type, Indication, End User, Distribution Channel, Route Of Administration, Company - Global Forecast to 2030 - Product Thumbnail Image

PD-1 & PD-L1 Inhibitors Market by Product Type, Indication, End User, Distribution Channel, Route Of Administration, Company - Global Forecast to 2030

  • Report
  • May 2025
  • 189 Pages
  • Global
From
Antacids Market Report 2025 - Product Thumbnail Image

Antacids Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Diverticulitis Disease Market Report 2025 - Product Thumbnail Image

Diverticulitis Disease Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Difficile-Associated Diarrhea Treatment Market Report 2025 - Product Thumbnail Image

Difficile-Associated Diarrhea Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Claudin 18.2-Targeted Immunotherapy: A Landscape Analysis of Stakeholders, Drug Modalities, Pipeline and Business Opportunities from An Industry Perspective - Product Thumbnail Image

Claudin 18.2-Targeted Immunotherapy: A Landscape Analysis of Stakeholders, Drug Modalities, Pipeline and Business Opportunities from An Industry Perspective

  • Report
  • August 2023
  • 267 Pages
  • Global
From
High Potency Active Pharmaceutical Ingredients Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

High Potency Active Pharmaceutical Ingredients Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • June 2025
  • 269 Pages
  • Global
From
Biopharmaceuticals - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Thumbnail Image

Biopharmaceuticals - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • July 2024
  • 208 Pages
  • Global
From
Anti-Inflammatory Therapeutics Market by Therapeutic Class, Mechanism Of Action, Route Of Administration, Distribution Channel, Indication, End User - Global Forecast to 2030 - Product Thumbnail Image

Anti-Inflammatory Therapeutics Market by Therapeutic Class, Mechanism Of Action, Route Of Administration, Distribution Channel, Indication, End User - Global Forecast to 2030

  • Report
  • May 2025
  • 198 Pages
  • Global
From
Interferon Market by Indication, Interferon Type, Administration Route, End User, Product Type, Dosage Form - Global Forecast to 2030 - Product Thumbnail Image

Interferon Market by Indication, Interferon Type, Administration Route, End User, Product Type, Dosage Form - Global Forecast to 2030

  • Report
  • May 2025
  • 193 Pages
  • Global
From
Breast Cancer Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Breast Cancer Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Cellular Immunotherapy - Global Strategic Business Report - Product Thumbnail Image

Cellular Immunotherapy - Global Strategic Business Report

  • Report
  • July 2025
  • 386 Pages
  • Global
From
Oropharyngeal Cancer Diagnosis and Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Oropharyngeal Cancer Diagnosis and Therapeutics - Global Strategic Business Report

  • Report
  • July 2025
  • 395 Pages
  • Global
From
Esophageal Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Esophageal Cancer Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 269 Pages
  • Global
From
Adrenocortical Carcinoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Adrenocortical Carcinoma Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 289 Pages
  • Global
From
Blood Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Blood Cancer Therapeutics - Global Strategic Business Report

  • Report
  • July 2025
  • 291 Pages
  • Global
From
Neuroendocrine Tumors Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Neuroendocrine Tumors Therapeutics - Global Strategic Business Report

  • Report
  • July 2025
  • 171 Pages
  • Global
From
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4) Inhibitors - Global Strategic Business Report - Product Thumbnail Image

CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4) Inhibitors - Global Strategic Business Report

  • Report
  • July 2025
  • 275 Pages
  • Global
From
Testicular Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Testicular Cancer Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 269 Pages
  • Global
From
Metastatic Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Metastatic Cancer Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 377 Pages
  • Global
From
Personalized Cancer Medicines - Global Strategic Business Report - Product Thumbnail Image

Personalized Cancer Medicines - Global Strategic Business Report

  • Report
  • July 2025
  • 267 Pages
  • Global
From
Loading Indicator